PharmAthene (PIP)

Add to Watchlists
Create an Alert
1.42 -0.02  -1.39% AMEX Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
PIP Price Chart
View All Events

PIP Events

Date Type Description
Mar 11 Misc PharmAthene, Inc. Q4 2013 Earning Conference Call
Mar 11 Earnings PharmAthene, Inc. Q4 2013 Earning Result. Estimate: -0.03.
Dec 03 Misc SGM Event for PharmAthene Inc
Nov 07 Earnings Pharmathene Reports Third Quarter 2013 Financial and Operational Results. Estimate: -0.03.
Nov 07 Misc Pharmathene Reports Third Quarter 2013 Financial and Operational Results Conference Call
Aug 07 Misc Pharmathene to Host Second Quarter 2013 Conference Call and Webcast on Wednesday, August 7, 2013
Aug 07 Earnings Financial and Operating Results for the Second Quarter. Estimate: -0.03.
Aug 01 Misc Portfolio of Clinical-stage Therapeutic Candidates Addressing High-value Indicationsvalidated, Proprietary Human Monoclonal Antibody Discovery Platformmanagement to Host Conference Call Today at 9:00 a.m. Etannapolis, Md. And Seattle, Aug. 1, 2013 /P
Jun 11 Misc AGM Event for PharmAthene Inc
May 08 Misc PharmAthene to Host First Quarter 2013 Conference Call and Webcast on Wednesday, May 8, 2013
View All Performance Charts

PIP Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). PharmAthene is down 13.41% over the last year vs S&P 500 Total Return up 22.72%, Grifols up 28.90%, and Siga Technologies down 15.20%.

Get Quote for
Advertisement

Portfolio Strategies Featuring PIP

Did PharmAthene make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

PIP Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Maryland
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

PharmAthene, Inc. is a biodefense company. It is engaged in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States.

Recent Quotes

Symbol Price Chg Chg % Market Cap
PIP 1.42 -0.02 -1.39% 74.27M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.